Chrome Extension
WeChat Mini Program
Use on ChatGLM

15908 Long-term efficacy and safety of brodalumab in patients with or without metabolic syndrome

Journal of The American Academy of Dermatology(2020)

Cited 1|Views1
No score
Abstract
Background: We assessed the long-term efficacy and safety of brodalumab, a fully human anti–interleukin-17 receptor A monoclonal antibody, in patients with moderate to severe plaque psoriasis, stratified by baseline metabolic syndrome (MetSyn) status.
More
Translated text
Key words
brodalumab,metabolic,long-term
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined